UC San Diego researchers develop prototype pacifier that measures infant glucose noninvasively

October 29, 2019
Digital Transformation More...
Average importance

The device collects saliva in a reservoir behind the nipple, and when it comes in contact with an enzyme-coated sensor, the amount of saliva present is measured. The prototype includes a separate 3D-printed microfluidics component, which is likely to be consolidated into one piece with the nipple when put into production for more widespread use. While it is not likely to be useful in general infant care, there is potential for its use in neonatal intensive care units in order to minimize the stress on babies that are already having much more invasive monitoring of their vitals. Sensors clients looking to play in the diabetes space should monitor these developments.

For the original news article, click here .

Further Reading

Goodbye lancets: Noninvasive glucose monitoring is here

Analyst Insight | July 29, 2020

With well more than $1 trillion at stake in diabetes care and management, this is an area that justifies the significant innovation money being spent. The market is massive, eclipsed only by the scope of the unmet needs for diagnosis, monitoring, and treatment. Almost all those efforts today are ... Not part of subscription

Wearable electrochemical biosensors: Opportunities and challenges

Analyst Insight | December 02, 2020

Introduction Continuous biosensing has been a hot topic for the healthcare and personal care industries. As semiconductor technologies and flexible electronics advance, sensors are becoming much smaller, more energy‑efficient, and more suitable for wearable devices, thereby allowing for ... Not part of subscription

Emerging go-to-market strategies overcome regulatory and reimbursement hurdles to tap into the $4 trillion health and wellness market

Analyst Insight | December 02, 2020

Currently, the most common approach to a new healthcare solution is building it with a particular set of insurance reimbursement codes in mind (see this insight), getting clinical validation as part of the regulatory approval process, and deploying to the market with a reimbursement plan already in ... Not part of subscription